Sign Up Today and Learn More About Granite Bio Stock
Invest in or calculate the value of your shares in Granite Bio or other pre-IPO companies through EquityZen's platform.
Granite Bio Stock
Granite Bio is a biotechnology business developing novel antibodies to treat inflammatory, autoimmune, and fibrotic disorders.
About Granite Bio Stock
Founded
2021
Industries
Content and Publishing, Messaging and Telecommunications, Sports
Granite Bio Press Mentions
Stay in the know about the latest news on Granite Bio
In other news this week: Granite Bio emerges from stealth with €87.6M, Didomi bags €72M, First Momentum Ventures closes €35M, and more
siliconcanals • Apr 26, 2025
Vyne Crashes After Safety Signal in Dogs Puts Hold on Clinical Trial of Plaque Psoriasis
biospace • Apr 26, 2025
Granite Bio makes $100m debut, and other bio financings
pharmaphorum • Apr 26, 2025
Chutes & Ladders—Galapagos CEO eyes exit as spinout names leader
fiercebiotech • Apr 26, 2025
Granite Bio: Immunology Company Debuts With $100 Million In Funding
pulse2 • Apr 26, 2025
Granite Bio Management
Leadership team at Granite Bio
Founder
Matthias Mack
Board Member
Rogier Rooswinkel
Join now and verify your accreditation status to gain access to:
- Granite Bio Current Valuation
- Granite Bio Stock Price
- Granite Bio Management
- Available deals in Granite Bio and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Granite Bio Cap Table and Funding History by Share Class and Liquidity Preferences
- Granite Bio Revenue and Financials
- Granite Bio Highlights
- Granite Bio Business Model
- Granite Bio Risk Factors
- Granite Bio Research Report from SACRA Research
Trading Granite Bio Stock
How to invest in Granite Bio stock?
Accredited investors can buy pre-IPO stock in companies like Granite Bio through EquityZen funds. These investments are made available by existing Granite Bio shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Granite Bio stock?
Shareholders can sell their Granite Bio stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."